SLRN

HEALTHCARE

Acelyrin Inc

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving SLRN Today?

No stock-specific AI insight has been generated for SLRN yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$229M

P/E Ratio—

EPS$-2.69

Dividend Yield—

Dividend / Share—

ROE-0.5%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding101.0M

SLRN News

No news articles found for SLRN yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$2.56

52 Week Low$1.95

Fundamentals

Market Cap$229M

P/E Ratio—

EPS$-2.69

Dividend Yield—

Dividend / Share—

ROE-0.5%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding101.0M

About Acelyrin Inc

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company is headquartered in Agoura Hills, California.

acelyrin.com

Listed May 4, 2023

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—